Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
An unpublished study by the investigators on healthy participants has shown that the
supplementation of oil palm phenolics (OPP) at 250 mg is the optimum dose to demonstrate the
ability to lower total and LDL cholesterol. There is no clinical evidence as yet on that
optimum dosage of OPP supplementation in improving fasting lipid profile in minor
hyperlipidemia subjects. The investigators hypothesize that in a clinical study, OPP
supplemented to the minor hyperlipidemic participants will elicit a reduction in total and
LDL cholesterol while maintaining safety and tolerability. OPP may have the potential to be
positioned as natural health supplement in improving lipid profile.